These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 23560381

  • 1. Reversing resistance of multidrug-resistant hepatic carcinoma cells with parthenolide.
    Liu D, Liu Y, Liu M, Ran L, Li Y.
    Future Oncol; 2013 Apr; 9(4):595-604. PubMed ID: 23560381
    [Abstract] [Full Text] [Related]

  • 2. TFPI-2 downregulates multidrug resistance protein in 5-FU-resistant human hepatocellular carcinoma BEL-7402/5-FU cells.
    Lu F, Hou YQ, Song Y, Yuan ZJ.
    Anat Rec (Hoboken); 2013 Jan; 296(1):56-63. PubMed ID: 23125179
    [Abstract] [Full Text] [Related]

  • 3. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
    Chen Z, Ma T, Huang C, Zhang L, Lv X, Xu T, Hu T, Li J.
    Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051
    [Abstract] [Full Text] [Related]

  • 4. MEL-pep, an analog of melittin, disrupts cell membranes and reverses 5-fluorouracil resistance in human hepatocellular carcinoma cells.
    Ke M, Dong J, Wang Y, Zhang J, Zhang M, Wu Z, Lv Y, Wu R.
    Int J Biochem Cell Biol; 2018 Aug; 101():39-48. PubMed ID: 29800725
    [Abstract] [Full Text] [Related]

  • 5. Design and synthesis of parthenolide and 5-fluorouracil conjugates as potential anticancer agents against drug resistant hepatocellular carcinoma.
    Ding Y, Li S, Ge W, Liu Z, Zhang X, Wang M, Chen T, Chen Y, Zhang Q.
    Eur J Med Chem; 2019 Dec 01; 183():111706. PubMed ID: 31553932
    [Abstract] [Full Text] [Related]

  • 6. Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells.
    Gu W, Liu L, Fang FF, Huang F, Cheng BB, Li B.
    Oncol Rep; 2014 Jan 01; 31(1):216-22. PubMed ID: 24173654
    [Abstract] [Full Text] [Related]

  • 7. [Establishment of a multidrug-resistant cell line BEL-7402/5-FU of human hepatocellular carcinoma and its biological characteristics].
    Gu W, Zhang YN, Li B, Han J, Cheng BB, Ling CQ.
    Zhong Xi Yi Jie He Xue Bao; 2006 May 01; 4(3):265-70. PubMed ID: 16696913
    [Abstract] [Full Text] [Related]

  • 8. Characterization and resistance mechanisms of a 5-fluorouracil- resistant hepatocellular carcinoma cell line.
    Gu W, Fang FF, Li B, Cheng BB, Ling CQ.
    Asian Pac J Cancer Prev; 2012 May 01; 13(9):4807-14. PubMed ID: 23167424
    [Abstract] [Full Text] [Related]

  • 9. Opsin3 sensitizes hepatocellular carcinoma cells to 5-fluorouracil treatment by regulating the apoptotic pathway.
    Jiao J, Hong S, Zhang J, Ma L, Sun Y, Zhang D, Shen B, Zhu C.
    Cancer Lett; 2012 Jul 01; 320(1):96-103. PubMed ID: 22313545
    [Abstract] [Full Text] [Related]

  • 10. Reversal of P-glycoprotein-mediated multidrug resistance of human hepatic cancer cells by Astragaloside II.
    Huang C, Xu D, Xia Q, Wang P, Rong C, Su Y.
    J Pharm Pharmacol; 2012 Dec 01; 64(12):1741-50. PubMed ID: 23146037
    [Abstract] [Full Text] [Related]

  • 11. Reversal effect of 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU.
    Huang HY, Niu JL, Zhao LM, Lu YH.
    Phytomedicine; 2011 Sep 15; 18(12):1086-92. PubMed ID: 21596545
    [Abstract] [Full Text] [Related]

  • 12. [Expression of ERK5 in multidrug-resistant hepatocellular carcinoma cell line].
    Yan F, Wang XM, Pan C.
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar 15; 29(3):483-6. PubMed ID: 19304531
    [Abstract] [Full Text] [Related]

  • 13. [Reversal of multidrug resistance of human hepatocellular carcinoma cells by wild-type p53 gene and related mechanisms].
    Gai XD, Li GL, Huang JZ, Xue HJ, Wang D.
    Ai Zheng; 2006 Aug 15; 25(8):954-9. PubMed ID: 16965674
    [Abstract] [Full Text] [Related]

  • 14. Silencing the EZH2 gene by RNA interference reverses the drug resistance of human hepatic multidrug-resistant cancer cells to 5-Fu.
    Zhang Y, Liu G, Lin C, Liao G, Tang B.
    Life Sci; 2013 May 20; 92(17-19):896-902. PubMed ID: 23562851
    [Abstract] [Full Text] [Related]

  • 15. The Effects and Mechanisms of Periplaneta americana Extract Reversal of Multi-Drug Resistance in BEL-7402/5-FU Cells.
    Yuan F, Liu J, Qiao T, Li T, Shen Q, Peng F.
    Molecules; 2016 Jun 28; 21(7):. PubMed ID: 27367657
    [Abstract] [Full Text] [Related]

  • 16. The noncytotoxic dose of sorafenib sensitizes Bel-7402/5-FU cells to 5-FU by down-regulating 5-FU-induced Nrf2 expression.
    Zhou S, Ye W, Duan X, Zhang M, Wang J.
    Dig Dis Sci; 2013 Jun 28; 58(6):1615-26. PubMed ID: 23314856
    [Abstract] [Full Text] [Related]

  • 17. Annonaceous acetogenins reverses drug resistance of human hepatocellular carcinoma BEL-7402/5-FU and HepG2/ADM cell lines.
    Qian JQ, Sun P, Pan ZY, Fang ZZ.
    Int J Clin Exp Pathol; 2015 Jun 28; 8(9):11934-44. PubMed ID: 26617951
    [Abstract] [Full Text] [Related]

  • 18. Synergistic antitumor effect of 5-fluorouracil in combination with parthenolide in human colorectal cancer.
    Kim SL, Kim SH, Trang KT, Kim IH, Lee SO, Lee ST, Kim DG, Kang SB, Kim SW.
    Cancer Lett; 2013 Jul 28; 335(2):479-86. PubMed ID: 23507557
    [Abstract] [Full Text] [Related]

  • 19. Mechanism of 5-fluorouracil required resistance in human hepatocellular carcinoma cell line Bel(7402).
    Jin J, Huang M, Wei HL, Liu GT.
    World J Gastroenterol; 2002 Dec 28; 8(6):1029-34. PubMed ID: 12439919
    [Abstract] [Full Text] [Related]

  • 20. [Establishment of a 5-DFUR-resistant human hepatocellular carcinoma cell model and preliminary study of the mechanisms of the drug resistance].
    Tang H, Liang P, Li RP.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Nov 28; 28(11):2006-8. PubMed ID: 19033114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.